Year: 2017
Type: article
Abstract: Cancer is still a major threat to public health worldwide.Thanks to the extensive studies in cancer biology and growing understanding in cancer, many novel and effective therapeutic agents and drug combinations have been discovered and designed.However, many of them are challenged in reaching their targeted site.Nano-scaled drug carriers that target and deliver therapeutic agents to the sites of diseases have shown great promises in cancer treatment.As a starting point, we designed a human epidermal growth factor receptor 2 (HER-2) targeting pH sensitive nanoparticle combining the advantages of polyhistidine (PHis) and Herceptin.This nanoparticle contains a pH sensitive hydrophobic core in which chemotherapeutic drug is loaded and hydrophilic layer which stabilizes the whole nanoparticle while providing active targeting to HER-2.This nanoparticle shows a pH triggered drug release (i.e.fast drug release at acidic condition and sustained release at physiological condition), a capability of endosomal escape which allows delivery of cargo to cytoplasm, and HER-2 targeting which enhances cellular uptake of the nanoparticle.This work is described in detail in chapter 2.In addition, there are growing needs in delivery of micro RNA inhibitor (miRi) for RNA interferences (RNAi).In chapter 3, a novel lipid coated calcium phosphate miRi complex was made to address poor encapsulation of hydrophilic RNA molecules in hydrophobic polymeric core for co-delivery of molecules with different physicochemical properties.This novel complex was co-encapsulated with paclitaxel in nanoparticle to achieve co-delivery.The co-delivery nanoparticle was found effective in regulating gene Waltz, Dr. Ho, and Dr.
Author: Zilan Zhou
Institution: University of Cincinnati
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W2765684989
